ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/S-[2,3-Bis[(1-oxohexadecyl)oxy]propyl]-N-(1-oxohexadecyl)-L-cysteinyl-L-seryl-L-lysyl-L-lysyl-L-lysyl-L-lysine
C81H156N10O13S
1510.2 g/mol
Research Reagent

Pam3Cys-Ser-(Lys)4

CAS112208-00-1
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

Pam3Cys-Ser-(Lys)4 is a lipopeptide research compound consisting of a triacylated cysteine linked to a serine and four lysine residues. It is primarily used as a laboratory reagent for studying neutrophil activation, specifically the induction of superoxide formation and lysozyme release in human neutrophils.

Research compound for neutrophil activationInduction of superoxide formation in human neutrophilsStimulation of lysozyme release

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Pam3Cys-Ser-(Lys)4?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

ReferenceSame Category

N-Methyl-6-nitroso-3,4-dihydro-2H-1,4-thiazin-5-amine--hydrogen chloride (1/1)

CAS112233-23-5

research compound

ReferenceSame Category

2-Acetamido-7H-purin-6-yl diphenylcarbamate

CAS112233-74-6

research compound

ReferenceSame Category

(+)-diisopinocampheyl chloroborane

CAS112246-73-8

research compound

ReferenceSame Category

16-Amino-4,6,9,12,15-pentahydroxy-10-[(1H-imidazol-5-yl)methyl]-N-(1-methoxy-1-oxo-3-phenylpropan-2-yl)-2-methyl-7-(2-methylpropyl)-17-phenyl-3,8,11,14-tetraazaheptadeca-3,8,11,14-tetraen-1-imidic aci d

CAS112317-45-0

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2R)-3-[2,3-di(hexadecanoyloxy)propylsulfanyl]-2-(hexadecanoylamino)propanoyl]amino]-3-hydroxypropanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid

InChIKey

OEDPHAKKZGDBEV-GFPBKZJXSA-N

SMILES

CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O

Synonyms (11)
  • Pam3CSK4 TFA
  • Pam3Cys-Ser-(Lys)4

Sourcing Pam3Cys-Ser-(Lys)4?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→